Virtu Financial’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-363
| Closed | -$8K | – | 1682 |
|
|
2025
Q1 | $8K | Buy |
+363
| New | +$8K | ﹤0.01% | 1207 |
|
|
2024
Q4 | – | Sell |
-195
| Closed | -$3K | – | 1719 |
|
|
2024
Q3 | $3K | Buy |
+195
| New | +$3K | ﹤0.01% | 1260 |
|
|
2024
Q1 | – | Sell |
-343
| Closed | -$81K | – | 1656 |
|
|
2023
Q4 | $81K | Buy |
+343
| New | +$81K | 0.01% | 1071 |
|
|
2021
Q4 | – | Sell |
-541
| Closed | -$119K | – | 1886 |
|
|
2021
Q3 | $119K | Buy |
+541
| New | +$119K | 0.01% | 1087 |
|
|
2021
Q1 | – | Sell |
-128
| Closed | -$48K | – | 1767 |
|
|
2020
Q4 | $48K | Buy |
+128
| New | +$48K | 0.01% | 1236 |
|
|
2018
Q1 | – | Sell |
-125
| Closed | -$210K | – | 2190 |
|
|
2017
Q4 | $210K | Buy |
+125
| New | +$210K | 0.01% | 1625 |
|